Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.
1 While we acknowledge this meticulous work performed, we still think that the source of IL-1 and, therefore, the site of inflammasome activation is rather the diseased liver than circulating PBMC.